Product Information
Pomalidomide 4'-PEG3-acid is a pegylated form of pomalidomide, a medication used for the treatment of multiple myeloma. Pegylation involves attaching polyethylene glycol (PEG) molecules to a drug, which can enhance its therapeutic properties. In this case, Pomalidomide 4'-PEG3-acid is a PEG product that contains an amido PEG linker and an acid PEG moiety.
The pegylation of pomalidomide offers several advantages. It prolongs the drug's circulation time in the body, leading to improved bioavailability and reduced dosing frequency. Additionally, pegylation can enhance the drug's stability and reduce immunogenicity.
Pomalidomide 4'-PEG3-acid is specifically designed to enhance the pharmacokinetic profile of pomalidomide. The amido PEG linker ensures a stable attachment between pomalidomide and PEG, while the
Chemical properties
Technical inquiry about: 3D-NKD44082 Pomalidomide 4'-PEG3-acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
